OmniScience

🎉Exciting news - Vivo has taken 1st place at the CNS Summit 2024 Innovation Showcase! Vivo is setting a new standard for precision, transparency, and efficiency in clinical development. We’re honored to be recognized for Vivo’s transformative impact on clinical trial data management and excited for the future. Read our full release about this milestone and how Vivo is revolutionizing clinical trials are conducted ↴ https://lnkd.in/grqkDckk #cnssummit2024 #clinicaltrials #datascience

It was wonderful to travel to Atlanta last week to attend the external advisory board meeting for the Georgia Tech Emory Department of Biomedical Engineering. Sue Van spoke in honor of the 25th anniversary of the department. Sue was the CFO of the Coulter Corporation (the inventor of the Coulter Counter that made modern blood diagnostics possible) and now is the CEO of the Coulter Foundation. Sue wrote the check to create the Wallace H. Coulter Department of BME at Emory Georgia Tech, which has been ranked as the #1 program in the world (tied with Johns Hopkins). Sue's story of creating this department for translational research - linking a world class private medical school with a world class public engineering school - was a story of years of struggle. And she concluded with: "I did this for one reason - to save lives. I want to know about the return on my investment (as she looked around the room at many alumni) - with this education, with this department's research, have you saved lives?" Sue's unwavering determination to create the department from scratch, her clear eyed purpose to change the world with new innovation to improve health, and her normalization of how hard change actually is - was a powerful example and call to action. Thank you Sue. (And I got to hang with my grad school roommate Cecilia Joshi and go to a fun party at the Fox Theatre!) #georgiatech #emory #biomedicalengineering

🔗 Integrate Study Data: Vivo brings all of your data into a single portal, including EDCs, IRTs, PROs/COAs, labs, imaging, wearables, and more. Our platform ensures seamless data integration and harmonization, providing a comprehensive view of your clinical trial data across multiple vendor platforms. Learn how Vivo can streamline your clinical trials: → https://lnkd.in/gkbaQ4aC ← #clinicaltrials #biopharma #biotech #datascience

At OmniScience, we are dedicated to advancing life science missions. Our partnership with Prana Thoracic showcases the power of collaboration to uncover meaningful insights and improve patient care. In our joint white paper, “Majority of Cancerous Nodules Measuring 10 mm or Less in NLST Participants Determined to be Retrievable by the Prana System,” we analyzed data from the National Lung Screening Trial, a large, multi-year cancer screening study, to identify populations that could benefit from Prana's innovative medical device. We’re proud to contribute to projects that hold such significant potential for early detection and intervention. Thanks to the National Cancer Institute (NCI) for granting access to the NLST dataset to enable this important research. Here’s to continuing to push boundaries together! 🚀 #cancerresearch #datascience #oncology #clinicaltrials #medtech

GenAI is a hot topic across industries, but our clients are asking: how does genAI specifically benefit clinical development? In this post, our data science team outlines key use cases for clinical development teams to accelerate in a rapidly evolving market. Discover how Vivo sets a new standard for data insights, boosting trial success, optimizing decision-making, and driving operational efficiency. #genai #datascience #clinicaltrials https://lnkd.in/gAf-qFen

Thrilled to announce that Vivo has been licensed by ...futuresTHRIVE to help revolutionize pediatric mental health by enabling early detection of mental health concerns in young children with AI-driven insights. Learn how this collaboration is transforming care for children and empowering caregivers and clinicians with actionable data. Full announcement here: ⬇️ https://lnkd.in/egYNGewM #pediatrichealth #genaI #mentalhealth #lifesciences #datascience 

The fT tScreen™, for non-reading children aged five to nine, is a digital mental health screener that leverages AI to provide practitioners with the largest data set of mental health information possible. The fT TweenScreen™ is a similar tool for ages nine to sixteen. Both tools collect health data about Adverse Childhood Experiences™; Positive Childhood Experiences™; positive findings; relationships; routines; functioning in school, home, and with peers; family disruptions; anxiety; depression; and suicidality. Thank you TEAM! Charlee Gordon Tracy Beeson Patricia Gail Bray, PhD Amanda Craig, PhD, LMFT Eric Heikkila Realist Lab Christine Sullivan Douglas Noordsy Megan Girald Dr. Suzanne Kyle

Congratulations to Jonathan Gallion, PhD, who will be honored with the College of Science Early Career Award at the 2024 Alumni Awards this evening. After graduating from Oregon State University in 2012 with dual Honors bachelor degrees in biochemistry and biophysics and microbiology, he pursued graduate school before launching a people-centered career at the forefront of innovation. Now, Gallion is vice president of artificial intelligence and machine learning (AI/ML) for OmniScience, a leading AI organization focused on life sciences and clinical research. By harnessing the power of large language models in the biopharmaceutical (biopharma) industry, he and his team are changing the game. The objective isn’t to replace humans, but to create an industry-wide vision of how AI/ML can modernize human health, improve clinical trial outcomes, accelerate the decision-making process, and revolutionize data analysis for teams guiding biotech, medtech, pharmaceutical and preclinical innovations. Read more here: https://lnkd.in/grhimVS9

We’re honored to be the winner of the Innovation Showcase Award #CNS2024! Michael Bell, PhD, did an amazing job representing all of us at OmniScience presenting our product Vivo, the solution for the overwhelming amount of data in modern clinical trials at. https://lnkd.in/gdJtXf-n We are working toward a future where clinical trial teams have instant access the insights they need to ensure their trial has the best chance of success. No more spreadsheets, no more tracking IDs on sticky notes, no more failed trials due to issues that could have been identified early on with the right tools.

Attended the State of the Texas Medical Center to learn of their vision to build the most comprehensive and efficient ecosystem for life science in the world, taking new treatments from bench to patients faster than ever. With almost a billion in NIH funding, and more than 4900 active clinical trials (20% of our country's trials are run in the TMC), they are well on their way. When they surveyed the room of 100s of people how many knew someone whose life had been saved in the TMC, almost all hands went up. They even mentioned that at any time, there are more than 10,000 jobs open in the TMC - the scale of the clinical care is immense. Grateful to be part of the incredible momentum and impact those in the TMC network are making to bring better care to patients. Thank you for hosting Greater Houston Partnership and the invitation to attend with Verena Kallhoff, Ph.D., MBA.